|
Variables: corrected for centre
(results are presented as n (%) or median (IQR) | HFO (n = 80) | CMV (n = 91) | p-value |
| Length of ventilation (days) | 13 (8–23) | 10 (6–18) | 0.03 |
|
Severity CLD
No CLD Mild CLD Moderate CLD Severe CLD Died | 37 (46.3%) 7 (8.8%) 2 (2.5%) 9 (11.3%) 25 (31.3%) | 50 (54.9%) 13 (14.3%) 1 (1.1%) 6 (6.6%) 21 (23.1%) | 0.13 |
| ECMO (in ECMO centres only) | 24 (51.1%) | 16 (26.2%) | 0.007 |
| Inhaled nitric oxide | 45 (56.3%) | 39 (42.9%) | 0.045 |
| Sildenafil | 25 (31.3%) | 11 (12.1%) | 0.004 |
| Inotropics | 73 (91.3%) | 73 (80.2%) | 0.08 |
|
Duration inotropics (days)
(in survivors only) | 8 (4.25- 19) | 6 (3.25- 11.75) | 0.02 |